Microfluidic System with Compartmentalized Perfusion Paths
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for drug development and malaria research rely heavily on animal models and 2D cell cultures, which are costly, inefficient, and lack the complexity to accurately predict clinical efficacy and toxicity.
Innovation Solution
A microfluidic system with compartmentalized microenvironments and independent perfusion paths is developed to create tissue-engineered microenvironments that mimic the structural, biochemical, and mechanical aspects of tissues and organs, allowing for the culture of parasite stages and drug testing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional static 3D cultures are used, then structural and biochemical features are restored, but nutrient supply is limited and metabolic waste accumulates
Solution Approach 1:
The system divides the culture into multiple independent compartments, each with its own perfusion path. This segmentation allows independent control of nutrient supply and waste removal for different tissue regions, preventing accumulation of metabolic waste while maintaining structural integrity.
Solution Approach 2:
The invention implements dynamic perfusion through microfluidic channels that continuously flow nutrients and remove waste products. This hydraulic system replaces static diffusion-based nutrient supply with active flow-based transport, ensuring adequate nutrient delivery to all tissue regions.
2Reliability
If conventional 3D cultures are used, then physiological context is improved, but mechanical cues such as flow and perfusion are lacking
Solution Approach 1:
The system incorporates microfluidic perfusion channels that deliver controlled flow and mechanical stress to tissue compartments. This hydraulic architecture provides physiological mechanical cues including shear stress and pressure gradients that are essential for maintaining tissue function and structure.
Solution Approach 2:
The invention transitions from static culture to dynamic perfusion systems where flow rates, pressures, and composition can be adjusted in real-time. This dynamic control allows optimization of mechanical stimuli to match in vivo conditions while maintaining system manageability through automated control.
3Reliability
If animal models are used, then complex physiological context is provided, but cost and time consumption increase dramatically
Solution Approach 1:
The system creates simplified in vitro copies of key physiological features using human cells and engineered microenvironments. These synthetic tissue models replicate essential functions of organ systems without requiring whole animal organisms, dramatically reducing cost and time while maintaining predictive relevance for human responses.
Solution Approach 2:
The invention segments complex physiological systems into discrete, modular tissue compartments that can be independently cultured and tested. This modular approach allows focused study of specific organ functions or disease mechanisms without the complexity and ethical constraints of whole animal models.
4Ease of manufacture
If 2D cell line models are used, then cost and simplicity are improved, but predictive value decreases due to loss of physiological context
Solution Approach 1:
The system transitions from two-dimensional cell culture surfaces to three-dimensional tissue compartments with spatial organization. This dimensional enhancement restores cell-cell and cell-matrix interactions, creates physiological gradients, and maintains tissue architecture while remaining compatible with microfluidic perfusion and automated analysis.
Data Source
AI summary
A microfluidic system including a number of microfluidic devices having a first perfusion path and a second separate perfusion path; the microfluidic devices each also having a chamber containing a matrix, where the matrix surrounds at least one void whose lumen is in fluidic connection exclusively with the first perfusion path, where the at least one void is populated with at least one cell type in such way that the cells are in direct contact with the matrix; where the matrix is in fluidic connection exclusively with the second separate perfusion path. The microfluidic devices are integrated onto a platform; and each of the microfluidic devices mimics at least a partial organ module.